Insulin Resistance Blood Panel Test: UK Guide

An insulin resistance blood panel test is one of the most effective ways to detect early metabolic changes before they progress to type 2 diabetes or cardiovascular disease. Insulin resistance is common, often symptom-free in its early stages, and closely linked to conditions such as prediabetes, metabolic syndrome and polycystic ovary syndrome. This article explains which blood tests are used in UK practice, how to prepare for them, and how to interpret your results, so you can take informed steps to protect your long-term health.

What is insulin resistance and why does it matter?

Insulin resistance occurs when cells respond less effectively to insulin, causing the pancreas to overproduce it and raising the risk of prediabetes, type 2 diabetes, metabolic syndrome and cardiovascular disease. It is often silent early on, making blood testing essential for detection.

Insulin resistance is a condition in which the body's cells respond less effectively to insulin, causing the pancreas to produce progressively more of the hormone to maintain normal blood glucose levels. Insulin is a hormone secreted by the pancreas that allows glucose to enter cells and be used for energy. When cells become resistant to its effects, glucose accumulates in the bloodstream, placing sustained demand on the pancreas.

Over time, insulin resistance can progress to prediabetes and then to type 2 diabetes if it is not identified and addressed. Beyond blood glucose, insulin resistance is closely linked to a cluster of metabolic abnormalities, including raised triglycerides, low HDL cholesterol, elevated blood pressure and central adiposity, collectively described as metabolic syndrome.^[1] These changes significantly increase the risk of cardiovascular disease and metabolic fatty liver disease (also referred to as non-alcoholic fatty liver disease, or NAFLD, in older literature and now increasingly termed metabolic dysfunction-associated steatotic liver disease, or MASLD).^[4][5] Polycystic ovary syndrome (PCOS) is also strongly associated with insulin resistance, though PCOS is not a downstream consequence of metabolic syndrome; rather, insulin resistance is a common underlying feature shared by both conditions.

Insulin resistance is common and often silent in its early stages, meaning many people have no obvious symptoms. Subtle signs can include fatigue, difficulty losing weight, skin changes such as acanthosis nigricans (darkened patches in skin folds), and irregular menstrual cycles in women. Because symptoms are non-specific, blood testing is the most reliable way to identify related metabolic changes such as prediabetes and dyslipidaemia. Early detection matters because lifestyle changes, and in some cases medication, can substantially reduce the risk of progression to type 2 diabetes and its associated complications.

Which blood tests are used to check for insulin resistance in the UK?

UK clinicians use a panel including HbA1c, fasting plasma glucose, fasting lipid profile and, where available, fasting insulin and HOMA-IR to assess insulin resistance and related metabolic risk. No single test provides a definitive diagnosis.

No single blood test definitively diagnoses insulin resistance, but a panel of measurements together provides a clinically useful picture. In routine UK practice, testing is used to identify prediabetes, type 2 diabetes risk and related metabolic abnormalities rather than to diagnose insulin resistance as a standalone condition. The most commonly used tests include the following:

• HbA1c (glycated haemoglobin): Reflects average blood glucose over the preceding two to three months. NICE uses HbA1c thresholds to identify non-diabetic hyperglycaemia, sometimes called prediabetes (42 to 47 mmol/mol), and type 2 diabetes (48 mmol/mol or above). HbA1c may be unreliable in certain situations, including haemoglobinopathies, anaemia, pregnancy and chronic kidney disease; in these cases, fasting plasma glucose or an oral glucose tolerance test (OGTT) may be preferred.^[13][15]

• Fasting plasma glucose: Measures blood glucose after an overnight fast. A fasting glucose of 6.1 to 6.9 mmol/L suggests impaired fasting glucose, a marker associated with insulin resistance.

• Oral glucose tolerance test (OGTT): Involves measuring blood glucose before and two hours after a standard glucose drink. It is used when HbA1c is unreliable, to assess impaired glucose tolerance, and routinely in pregnancy to screen for gestational diabetes.

• Fasting insulin: Not routinely offered on the NHS and not recommended by NICE for standard diagnosis. It is available through some private providers. Elevated fasting insulin alongside normal or mildly raised glucose may suggest compensatory hyperinsulinaemia, but interpretation depends on the laboratory method used and local reference ranges.

• HOMA-IR (Homeostatic Model Assessment of Insulin Resistance): A calculated index derived from fasting glucose and fasting insulin. A higher HOMA-IR score indicates greater insulin resistance. NICE does not recommend HOMA-IR for routine clinical diagnosis, and reference ranges vary between laboratories, so results should be interpreted with caution and in clinical context.

• Fasting lipid profile: Raised triglycerides and low HDL cholesterol are strongly associated with insulin resistance and metabolic syndrome. Many UK laboratories now accept non-fasting samples for a standard lipid profile; however, triglyceride measurement is most accurate in the fasting state.^[16][17] Follow the instructions provided by the requesting clinician or laboratory.

• Liver function tests: May be requested if MASLD (previously NAFLD) is suspected alongside insulin resistance.

A GP may request some of these tests on the NHS if there is clinical concern, for example in someone with obesity, a family history of type 2 diabetes, or PCOS. Comprehensive panels including fasting insulin and HOMA-IR are more readily available through private blood testing services. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations, with prescriber review and pharmacist support, where clinicians can advise on appropriate testing pathways.

How do you prepare for an insulin resistance blood panel test?

Fasting tests such as fasting glucose, fasting insulin and triglycerides require an eight to twelve hour overnight fast with only plain water permitted; HbA1c does not require fasting. Always follow the specific instructions from your requesting clinician or laboratory.

Preparing correctly for an insulin resistance blood panel test is important because several key measurements are directly affected by recent food and drink intake. Fasting requirements depend on which tests have been requested: fasting glucose, fasting insulin and triglyceride measurement typically require an overnight fast, whereas HbA1c does not require fasting and many standard lipid profiles can be taken without fasting. Always follow the specific instructions provided by the requesting clinician or laboratory, as these take precedence.

For tests that do require fasting, most laboratories ask for a fast of eight to twelve hours before the blood draw, during which only plain water is permitted. Tea, coffee, fruit juice and other beverages can alter glucose and insulin levels even without added sugar, so they should be avoided during the fasting period.

There are several additional points to bear in mind before attending for testing:

• Medications: Some medicines, including corticosteroids, antipsychotics and certain blood pressure treatments, can affect glucose and insulin levels. Do not stop any prescribed medication without speaking to your GP first, but do inform the laboratory or requesting clinician of everything you are taking.

• Timing: Morning appointments are generally preferable, as fasting overnight is more practical and morning glucose and insulin values are most reproducible.

• Physical activity: Strenuous exercise in the 24 hours before the test can temporarily lower blood glucose and alter insulin sensitivity. Gentle activity is acceptable, but avoid intense training sessions immediately beforehand.

• Illness: Acute illness, infection or significant physiological stress can raise glucose and cortisol levels, potentially distorting results. If you are unwell on the day of your appointment, it is worth rescheduling.

• Alcohol: Avoid alcohol for at least 24 hours before the test, as it can affect both glucose metabolism and triglyceride levels.

If you are unsure whether your preparation is correct, contact the requesting clinician or the laboratory in advance.

What do your results mean and what happens next?

Results should be interpreted together; raised HbA1c, elevated fasting glucose, high triglycerides, low HDL and a raised HOMA-IR collectively indicate significant metabolic risk. Management includes lifestyle changes, possible referral to the NHS Diabetes Prevention Programme, and in some cases metformin.

Interpreting an insulin resistance blood panel requires looking at the results together rather than in isolation, because no single value tells the whole story. A raised HbA1c in the non-diabetic hyperglycaemia range (42 to 47 mmol/mol), combined with a fasting glucose above 6.0 mmol/L, elevated triglycerides, low HDL cholesterol and a HOMA-IR score above the laboratory's reference threshold, collectively suggest clinically significant metabolic risk associated with insulin resistance. Your clinician will interpret these values in the context of your symptoms, weight, family history and other risk factors.

Where HbA1c is used to identify or confirm a diagnosis of type 2 diabetes, a second confirmatory test is usually required unless classic symptoms of diabetes are present. In people where HbA1c is unreliable (for example, due to haemoglobinopathies, anaemia, pregnancy or chronic kidney disease), fasting plasma glucose or an OGTT may be used instead.^[13][15]

If you experience symptoms that may suggest significantly raised blood glucose, such as marked thirst, frequent urination, unexplained weight loss, vomiting or drowsiness, seek same-day medical advice from your GP or call NHS 111. These symptoms may indicate type 1 diabetes or another condition requiring prompt assessment.

If results suggest prediabetes or insulin resistance, NICE guidance supports a structured approach to management. The NHS Diabetes Prevention Programme (NHS DPP, also known as Healthier You) is available to people in England with a non-diabetic hyperglycaemia result and offers evidence-based lifestyle support, including dietary advice and physical activity guidance.^[2][3] Key lifestyle changes that improve insulin sensitivity include:

• Dietary modification: Reducing refined carbohydrates and ultra-processed foods, increasing fibre intake and following a balanced diet.

• Regular physical activity: Both aerobic exercise and resistance training improve insulin sensitivity independently of weight loss.^[19][20]

• Weight management: Even modest weight reduction of five to ten per cent of body weight can meaningfully improve insulin resistance markers.

• Sleep and stress: Poor sleep and chronic psychological stress raise cortisol, which worsens insulin resistance.

In some cases, a GP may consider metformin, particularly where lifestyle measures alone are insufficient or where there are additional risk factors. Use of metformin for diabetes prevention in people with prediabetes is off-label in the UK but may be considered in high-risk individuals in line with NICE guidance (PH38).^[2][3] If results are normal but symptoms persist, further investigation may be warranted. Contact your GP to discuss your results. Suspected adverse effects of any medicine can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions